PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
28352173-3	2017	This magnetic NP (GPC@NIRF-Fe3O4) with superparamagnetic behavior showed high stability and safety in physiological conditions.	ferryl iron	27-32	glycophorin C (Gerbich blood group)	Homo sapiens	18-21	
28352173-4	2017	In addition, GPC@NIRF-Fe3O4 achieved more specific uptake of human liver cancer cells than free Fe3O4 NPs.	ferryl iron	22-27	glycophorin C (Gerbich blood group)	Homo sapiens	13-16	
28352173-4	2017	In addition, GPC@NIRF-Fe3O4 achieved more specific uptake of human liver cancer cells than free Fe3O4 NPs.	ferryl iron	96-101	glycophorin C (Gerbich blood group)	Homo sapiens	13-16	
28352173-5	2017	Importantly, with superpara-magnetic iron oxide and strong NIR absorbance, GPC@NIRF-Fe3O4 NPs demonstrate prominent tumor-contrasted imaging performance both on fluorescent and T2-weighted magnetic resonance (MR) imaging modalities in a living body.	ferryl iron	84-89	glycophorin C (Gerbich blood group)	Homo sapiens	75-78	
28352173-6	2017	The relative MR signal enhancement of GPC@NIRF-Fe3O4 NPs achieved 5.4-fold improvement compared with NIR-Fe3O4 NPs.	ferryl iron	47-52	glycophorin C (Gerbich blood group)	Homo sapiens	38-41	
28352173-6	2017	The relative MR signal enhancement of GPC@NIRF-Fe3O4 NPs achieved 5.4-fold improvement compared with NIR-Fe3O4 NPs.	ferryl iron	105-110	glycophorin C (Gerbich blood group)	Homo sapiens	38-41	
28352173-7	2017	Therefore, GPC@ NIRF-Fe3O4 NPs may be potentially used as a candidate for dual-modal imaging of tumors with information covalidated and directly compared by combining fluorescence and MR imaging.	ferryl iron	21-26	glycophorin C (Gerbich blood group)	Homo sapiens	11-14